AS
Armen Shanafelt
Angel InvestorActiveArmen Shanafelt brings over 22 years of experience in the pharmaceutical, biotechnology, and diagnostic businesses to Lilly Ventures. Previo...
34
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Armen Shanafelt.
Investment Thesis & Strategy
As an angel investor, Armen Shanafelt invests in various stages across a range of industries, leveraging his extensive experience in the pharmaceutical, biotechnology, and diagnostic sectors.
Investment Activity
Deals per year over the last 6 years
3
20112
20121
20130
20141
20151
2016Portfolio Companies
Selected investments from their portfolio of 34 companies
T
Trinity Biosystems
Biotech · Seed, 0
V
Viracta Therapeutics
Biotech · Seed, 0
F
Fluidigm
Biotech · Series C+, 0
B
Bayhill Therapeutics
Biotech · Seed, 0
K
Kymera Therapeutics
Biotech · Series B, 2016
S
Surface Oncology
Biotech · Series B, 2015
A
Aeglea BioTherapeutics
Biotech · Series B, 2013
P
Protagonist Therapeutics
Biotech · Series B, 2012
S
Symic Biomedical
Biotech · Seed, 2012
R
Remon Medical Technologies
Other · , 2011
C
Cavion
Biotech · Seed, 2011
L
Lysosomal Therapeutics
Biotech · Seed, 2011
Frequently Asked Questions
Armen Shanafelt focuses on Pre-seed, Seed stage investments.
Related Investors
Elevate Ventures
Indianapolis, United States · 91 deals
Ting Gootee
Indianapolis, United States · 80 deals
Kristian Andersen
Indianapolis, United States · 40 deals
Eric Tobias
Indianapolis, United States · 40 deals
Don Aquilano
Indianapolis, United States · 30 deals
Tim Kopp
Indianapolis, United States · 20 deals